2nd Edition of International Cancer & Immuno-Oncology Conference
March 19-21, 2026 | Singapore
Cancer Metastatis
Metastasis, the malignant journey of cancer cells from their origin to distant organs, presents a formidable puzzle in oncological exploration. Unraveling its complexities is pivotal for crafting effective interventions. Scientists delve into the intricate interplay of genetic aberrations, tumor microenvironment nuances, and immune system dynamics fueling metastasis. Emerging therapies, including targeted molecular interventions and immunomodulation, hold promise in curtailing this deadly spread. Advanced imaging modalities offer a sharper lens for early detection, amplifying treatment efficacy. Collaborative synergy across disciplines drives the quest for breakthroughs against metastatic cancer, with personalized approaches on the horizon. As research navigates the labyrinth of metastasis, the prospect of tailored treatments illuminates a path towards brighter outcomes for patients battling the scourge of advanced cancer.
Rajvir Dahiya
University of California San Francisco, United States
Atif A Ahmed
University of Washington-Seattle Children’s Hospital, United States
Anyou Wang
DIFIBER LLC, United States
Paulo Cesar De Morais
Catholic University of Brasilia, Brazil
Allen Chen
Olympic Medical Center, United States
Shilpa S Dhar
UT MD Anderson Cancer Center, United States
Ritu Khanna
University of Manchester, United KingdomSubmit your abstract Today
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Integrative multi-omics reveals metabolic–stemness coupling and novel therapeutic targets in osteosarcoma chemoresistance
Jinyan Feng, Tianjin Medical University Cancer Institute and Hospital, China